{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:43:25Z","timestamp":1778546605884,"version":"3.51.4"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,5,3]],"date-time":"2024-05-03T00:00:00Z","timestamp":1714694400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,5,3]],"date-time":"2024-05-03T00:00:00Z","timestamp":1714694400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Ophthalmol"],"DOI":"10.1007\/s10792-024-03120-x","type":"journal-article","created":{"date-parts":[[2024,5,3]],"date-time":"2024-05-03T03:36:22Z","timestamp":1714707382000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["A case of choroidal neovascularization as a first manifestaion of systemic lupus erythematosus"],"prefix":"10.1007","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4305-0492","authenticated-orcid":false,"given":"Edmond","family":"Jalkh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-4362-6378","authenticated-orcid":false,"given":"Carla","family":"Abi Doumit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandre","family":"Schakal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4740-7663","authenticated-orcid":false,"given":"Joseph","family":"Nehme","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5496-0432","authenticated-orcid":false,"given":"Georges","family":"Sukkarieh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alex","family":"Jalkh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,5,3]]},"reference":[{"key":"3120_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/J.JAUT.2018.11.001","volume":"96","author":"A Fava","year":"2019","unstructured":"Fava A, Petri M (2019) Systemic lupus erythematosus: diagnosis and clinical management. J Autoimmun 96:1\u201313. https:\/\/doi.org\/10.1016\/J.JAUT.2018.11.001","journal-title":"J Autoimmun"},{"issue":"20","key":"3120_CR2","doi-asserted-by":"publisher","first-page":"12264","DOI":"10.3390\/ijms232012264","volume":"23","author":"W Lubo\u0144","year":"2022","unstructured":"Lubo\u0144 W, Lubo\u0144 M, Kotyla P, Mrukwa-Kominek E (2022) Understanding ocular findings and manifestations of systemic lupus erythematosus: update review of the literature. Int J Mol Sci 23(20):12264. https:\/\/doi.org\/10.3390\/ijms232012264","journal-title":"Int J Mol Sci"},{"issue":"12","key":"3120_CR3","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1016\/S0161-6420(96)30385-0","volume":"103","author":"J Cunningham","year":"1996","unstructured":"Cunningham J, Alfred PR, Irvine AR (1996) Central serous chorioretinopathy in patients with systemic lupus erythematosus. Ophthalmology 103(12):2081\u20132090. https:\/\/doi.org\/10.1016\/S0161-6420(96)30385-0","journal-title":"Ophthalmology"},{"issue":"3","key":"3120_CR4","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/J.AJO.2003.09.042","volume":"137","author":"HE Grossniklaus","year":"2004","unstructured":"Grossniklaus HE, Green WR (2004) Choroidal neovascularization. Am J Ophthalmol 137(3):496\u2013503. https:\/\/doi.org\/10.1016\/J.AJO.2003.09.042","journal-title":"Am J Ophthalmol"},{"key":"3120_CR5","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/J.AJO.2019.03.001","volume":"204","author":"A Invernizzi","year":"2019","unstructured":"Invernizzi A et al (2019) Five-year real-world outcomes of occult and classic choroidal neovascularization: data from the fight retinal blindness! project. Am J Ophthalmol 204:105\u2013112. https:\/\/doi.org\/10.1016\/J.AJO.2019.03.001","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"3120_CR6","first-page":"111","volume":"3","author":"O Journal","year":"2014","unstructured":"Journal O, Gallego-Pinazo R, Dolz-Marco R, G\u00f3mez-Ulla F, Mrejen S, Freund B (2014) Pachychoroid diseases of the macula. Med Hypothesis, Discov Innov Ophthalmol 3(4):111","journal-title":"Med Hypothesis, Discov Innov Ophthalmol"},{"issue":"4","key":"3120_CR7","doi-asserted-by":"publisher","first-page":"395","DOI":"10.5935\/0004-2749.20210076","volume":"84","author":"LGB de Azevedo","year":"2021","unstructured":"de Azevedo LGB et al (2021) Lupus retinopathy: epidemiology and risk factors. Arq Bras Oftalmol 84(4):395\u2013401. https:\/\/doi.org\/10.5935\/0004-2749.20210076","journal-title":"Arq Bras Oftalmol"},{"issue":"8","key":"3120_CR8","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1007\/S00296-018-4083-4","volume":"38","author":"G Seth","year":"2018","unstructured":"Seth G et al (2018) Lupus retinopathy: a marker of active systemic lupus erythematosus. Rheumatol Int 38(8):1495\u20131501. https:\/\/doi.org\/10.1007\/S00296-018-4083-4","journal-title":"Rheumatol Int"},{"issue":"9","key":"3120_CR9","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1002\/ART.1780310904","volume":"31","author":"FJ Stafford-Brady","year":"1988","unstructured":"Stafford-Brady FJ, Urowitz MB, Gladman DD, Easterbrook M (1988) Lupus retinopathy. Patterns, associations, and prognosis. Arthritis Rheum 31(9):1105\u20131110. https:\/\/doi.org\/10.1002\/ART.1780310904","journal-title":"Arthritis Rheum"},{"issue":"1","key":"3120_CR10","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/J.SURVOPHTHAL.2015.06.003","volume":"61","author":"E Papagiannuli","year":"2016","unstructured":"Papagiannuli E, Rhodes B, Wallace GR, Gordon C, Murray PI, Denniston AK (2016) Systemic lupus erythematosus: an update for ophthalmologists. Surv Ophthalmol 61(1):65\u201382. https:\/\/doi.org\/10.1016\/J.SURVOPHTHAL.2015.06.003","journal-title":"Surv Ophthalmol"},{"issue":"4","key":"3120_CR11","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1001\/ARCHOPHT.1986.01050160114025","volume":"104","author":"DA Jabs","year":"1986","unstructured":"Jabs DA, Fine SL, Hochberg MC, Newman SA, Heiner GG, Stevens MB (1986) Severe retinal vaso-occlusive disease in systemic lupus erythematous. Arch Ophthalmol 104(4):558\u2013563. https:\/\/doi.org\/10.1001\/ARCHOPHT.1986.01050160114025","journal-title":"Arch Ophthalmol"},{"issue":"9","key":"3120_CR12","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1136\/ARD.59.9.705","volume":"59","author":"O Ushiyama","year":"2000","unstructured":"Ushiyama O et al (2000) Retinal disease in patients with systemic lupus erythematosus. Ann Rheum Dis 59(9):705\u2013708. https:\/\/doi.org\/10.1136\/ARD.59.9.705","journal-title":"Ann Rheum Dis"},{"key":"3120_CR13","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1186\/1752-1947-5-243","volume":"5","author":"P Vihinen","year":"2011","unstructured":"Vihinen P, Paija O, Kivisaari A, Koulu L, Aho H (2011) Cutaneous lupus erythematosus after treatment with paclitaxel and bevacizumab for metastatic breast cancer: a case report. J Med Case Rep 5:243. https:\/\/doi.org\/10.1186\/1752-1947-5-243","journal-title":"J Med Case Rep"},{"key":"3120_CR14","unstructured":"cutaneous lupus erythematosus in a patient undergoing intravitreal bevacizumab injections: case report and review of the literature\u2014jddonline\u2014journal of drugs in dermatology. https:\/\/jddonline.com\/articles\/cutaneous-lupus-erythematosus-in-a-patient-undergoing-intravitreal-bevacizumab-injections-case-repor-S1545961613P1052X. Accessed 26 Mar 2023"},{"key":"3120_CR15","unstructured":"FIRST AID FOR THE USMLE STEP 2 CK, 10th edn. McGraw Hill"},{"key":"3120_CR16","doi-asserted-by":"publisher","first-page":"4","DOI":"10.23937\/2378-346X\/1410038","volume":"2","author":"S Chan","year":"2015","unstructured":"Chan S, Gottlieb CC (2015) Systemic lupus erythematosus presenting as acute posterior multifocal placoid pigment epitheliopathy case report and review of the ocular manifestations of systemic lupus erythematosus. Int J Ophthalmol Clin Res 2:4\u201312","journal-title":"Int J Ophthalmol Clin Res"},{"issue":"8","key":"3120_CR17","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/s0021-5155(02)00657-3","volume":"106","author":"M Sawa","year":"2002","unstructured":"Sawa M, Saito Y, Kameda C, Tano Y (2002) Ocular complications in systemic lupus erythematosus\u2013choroidal and retinal pigment epithelial changes. Nihon Ganka Gakkai Zasshi 106(8):474\u2013480. https:\/\/doi.org\/10.1016\/s0021-5155(02)00657-3","journal-title":"Nihon Ganka Gakkai Zasshi"},{"issue":"2","key":"3120_CR18","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1097\/IAE.0000000000002810","volume":"41","author":"MC Savastano","year":"2021","unstructured":"Savastano MC, Rispoli M, Lumbroso B (2021) The incidence of neovascularization in central serous chorioretinopathy by optical coherence tomography angiography. Retina 41(2):302\u2013308. https:\/\/doi.org\/10.1097\/IAE.0000000000002810","journal-title":"Retina"},{"issue":"7","key":"3120_CR19","first-page":"4811","volume":"61","author":"L Raja","year":"2020","unstructured":"Raja L et al (2020) Choroidal neovascularization mimics in chronic central serous chorioretinopathy; an optical coherence tomography angiography study. Invest Ophthalmol Vis Sci 61(7):4811\u20134811","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"34","key":"3120_CR20","doi-asserted-by":"publisher","first-page":"E26980","DOI":"10.1097\/MD.0000000000026980","volume":"100","author":"RY Kim","year":"2021","unstructured":"Kim RY, Ma GJ, Park WK, Kim M, Park YG, Park YH (2021) Clinical course after the onset of choroidal neovascularization in eyes with central serous chorioretinopathy. Medicine (Baltimore) 100(34):E26980. https:\/\/doi.org\/10.1097\/MD.0000000000026980","journal-title":"Medicine (Baltimore)"}],"container-title":["International Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-024-03120-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10792-024-03120-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-024-03120-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T15:27:35Z","timestamp":1741879655000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10792-024-03120-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,3]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3120"],"URL":"https:\/\/doi.org\/10.1007\/s10792-024-03120-x","relation":{},"ISSN":["1573-2630"],"issn-type":[{"value":"1573-2630","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,3]]},"assertion":[{"value":"4 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of the Eye and Ear Hospital International.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}],"article-number":"212"}}